Stock-outs of antimalarials cause unnecessary deaths among an estimated 219 million people afflicted worldwide. Good pharmaceutical information systems can avoid stock-outs with timely, accurate data and high reporting rates that ensure the continuous availability of critically-needed antimalarials.
...
The US Agency for International Development (USAID)-funded Systems for Increased Access to Pharmaceuticals and Services (SIAPS) Program, with support from the US Government’s Presidential Malaria Initiative (PMI), is working with the Government of Guinea to improve the national malaria reporting system. By the end of September 2013, after only a few months of training in all 19 PMI-supported zones, reporting rates had improved significantly, reaching an average completion rate of 85 percent for health facilities during the previous quarter.
more
the Lancet : Published Online July 31, 2015 http://dx.doi.org/10.1016/S0140-6736(15)61117-5
Lancet Global Health 2017 Published Online February 22, 2017 http://dx.doi.org/10.1016/S2214-109X(17)30078-5
Ces affiches et brochures ont été produites en mars 2020 en réponse à la crise du COVID-19.
These posters and brochures were produced in March 2020 as a response to the COVID-19 crisis.
The New England Journal of Medicine
Genetic analysis of the virus indicates that it is closely related (97% identical) to variants of Ebola virus (species Zaire ebolavirus) identified earlier in the Democratic Republic of the Congo and Gabon
PLEASE download the article from the website!!
PLOS Neglected Tropical Diseases. Open Access. Please download the pdf-file from the website!
The Lancet. Published Online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32621-6. Open Access
n this study, low-dose azithromycin did not meet the prespecified non-inferiority margin compared with standard-dose azithromycin in achieving clinical and serological cure in PCR-confirmed active yaws. Only a single participant (with presumed latent yaws) had definitive serological failure. This wo
...
rk suggests that 20 mg/kg of azithromycin is probably effective against yaws, but further data are needed.
more
PERC produces regional and member state situation analyses, updated regularly.
- Regional analysis of acute food insecurity: Current situation (February-March 2015)
Emerg Infect Dis. 2017 Aug (Accessed July 18,2017)
Abstract: We report 77 cases of occupational exposures for 57 healthcare workers at the Ebola Treatment Center in Conakry, Guinea, during the Ebola virus disease outbreak in 2014-2015. Despite the
...
high incidence of 3.5 occupational exposures/healthcare worker/year, only 18 percent of workers were at high risk for transmission, and no infections occurred.
more
People with Guinea worm disease (GWD) have no symptoms for about 1 year. Then, the person begins to feel ill. Symptoms can include the following:
Slight fever
Itchy rash
Nausea
Vomiting
Diarrhea
Dizziness
A blister then develops. This blist
...
er can form anywhere on the skin. However, the blister forms on the lower body parts in 80%–90% of cases. This blister gets bigger over several days and causes a burning pain. The blister eventually ruptures, exposing the worm. The infected person may put the affected body part in cool water to ease the symptoms or may enter water to perform daily tasks, such as fetching drinking water. On contact with water, the worm discharges hundreds of thousands of larvae into the water.
more
The pharmacological treatment of heart failure has evolved over the last three decades since the demonstration of the effect of angiotensinconverting enzyme inhibitors on major cardiovascular events in patients with heart failure with reduced ejection fraction. Composite analysis of heart failure wi
...
th reduced ejection fraction trials and the recent identification of newer drug treatments show early benefits on the major cardiovascular outcomes, ushering in a change of the treatment strategy; from a ‘sequential’ initiation of the treatments to a ‘simultaneous’ initiation to harness the early benefits. The adoption and implementation of these changes at the bedside have been dismal in many healthcare settings. Papua New Guinea, like many other lower-to-middle-income countries, is facing many barriers that impact on the care of heart failure patients. It needs to adopt and implement these changes to provide evidence-based treatment for its people with heart failure with reduced ejection fraction.
more